Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 1, 1997, Pages 13-16

  Martin, M V ^a   Yates, J ^a   Hitchcock, C A ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; VORICONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ENDOCARDITIS; FEMORAL VEIN; GUINEA PIG; HEART CATHETERIZATION; INFECTION CONTROL; INTRAPERITONEAL DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 0031030033     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.1.13     Document Type: Article

References (17)

1. Bradford, C. R., A. G. Prentice, D. W. Warnock, and J. A. Copplestone. 1991. Comparison of the multiple dose pharmacokinetics of two formulations of itraconazole during remission induction of acute myeloblast leukaemia. J. Antimicrob. Chemother. 28:555-560.
2. Carrizoza, J., C. Kohn, and M. E. Levision. 1975. Experimental Aspergillus endocarditis in rabbits. J. Lab. Clin. Med. 86:746-753.
3. Coutlee, F., A. M., Carceller., L. Deschamps, C. Kratz J. R. Lapointe, and A. Davigion. 1990. The evolving pattern of pediatric endocarditis from 1960-1985. Can. J. Cardiol. 6:164-170.
4. Denning, D. W., and D. A. Stevens. 1990. Antifungal and surgica treatment of invasive aspergillosis: a review of 2121 published cases. Rev. Infect. Dis. 12:1147-1201.
5. Denning, D. W., R. M. Tucker, L. H. Hanson, and D. A. Stevens. 1988. Treatment of invasive aspergillosis with itraconazole. Am. J. Med. 86:791-800.
6. Denning, D. W., A. del Favero, E. Gluckman, D. Norfolk, M. Ruhnke, N. Sarantis, P. F. Troke, and S. Yonren. 1995. UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: clinical efficacy in acute invasive aspergillosis, abstr. F80, p. 126. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington DC.
7. Dupont, B., D. Denning, H. Lode, N. Sarantis, P. F. Troke, and S. Yonren. 1995. UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: clinical efficacy in chronic invasive aspergillosis, abstr. F81, p. 127. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
8. George, D., P. Minter, and V. T. Andriole. 1996. Efficacy of UK-109,496, a new azole antifungal agent, in an experimental model of invasive aspergillosis. Antimicrob. Agents Chemother. 40:86-91.
9. Grant, S. M., and S. P. Clissold. 1989. Itraconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 37:310-344.
10. Hitchcock, C. A., G. W. Pye, G. P. Oliver, and P. F. Troke. 1995. UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: antifungal activity and selectivity in vitro, abstr. F72, p. 125. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
11. Hitchcock, C. A., R. J. Andrews, B. G. H. Lewis, and P. F. Troke. 1995. UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: antifungal activity in experimental infections with Aspergillus, abstr. F74, p. 125. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
12. Jezequel, S. G., M. Clark, S. Cole, K. E. Evans, and P. Wastall. 1995. UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: pre-clinical pharmacokinetics, abstr. F76, p. 126. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. Longman, L. P., and M. V. Martin. 1987. A comparison of the efficacy of itraconazole, amphotericin B and 5-flucytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit. J. Antimicrob. Chemother. 20:719-724.
14. Patterson, B. E., and P. E. Coates. 1995. UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: pharmacokinetics in man, abstr. F78, p. 126. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
15. Pfizer Central Research. Data on file. Pfizer Central Research, Sandwich, United Kingdom.
16. Rubenstein, E., and R. Lang. 1995. Fungal endocarditis. Eur. Heart J. 16(Suppl. B):84-89.
17. Woestenborghs, R., W. Lorreyne, and J. Heykants. 1987. Determination of itraconazole in plasma and animal tissues by HPLC. J. Chromatogr. 413: 332-337.